Citius pharmaceuticals, inc. provides business update, highlights upcoming milestones

Cranford, n.j. , may 3, 2022 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today provided a business update for the first quarter ended march 31, 2022 and reported on recent corporate developments and upcoming milestones.
CTXR Ratings Summary
CTXR Quant Ranking